Eastman Chemical Form 8-K Dated October 28, 2004
| EASTMAN CHEMICAL COMPANY - EMN |
|
October 28, 2004 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities and Exchange Act of 1934
EASTMAN CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
|
Delaware |
|
1-12626 |
|
62-1539359 |
|
(State or other jurisdiction of |
|
(Commission |
|
(I.R.S. employer |
|
incorporation or organization) |
|
File Number) |
|
identification No.) |
|
100 N. Eastman Road, Kingsport, TN |
|
37660 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (423) 229-2000
| EASTMAN CHEMICAL COMPANY - EMN |
|
October 28, 2004 |
Item 2.02 Results of Operations and Financial Condition
On October 28, 2004, the registrant publicly released its financial results for the third quarter 2004. The full text of the release is furnished as Exhibit 99.01 to this Form 8-K, and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
This Form 8-K includes the following non-GAAP financial measures:
| |
· |
Net earnings and diluted earnings per share excluding asset impairments and restructuring charges, other operating income, and a net deferred tax benefit. |
| |
· |
Operating earnings excluding asset impairments and restructuring charges. |
| |
· |
Eastman Chemical Company and Eastman Division sales revenue excluding restructured, divested, and consolidated product lines sales revenue from the coatings, adhesives, specialty polymers and inks (CASPI) segment. |
Eastman’s management believes that the asset impairments and restructuring charges, other operating income, net deferred tax benefit, and corporate and Eastman Division sales revenue including restructured, divested, and consolidated product lines sales revenue from the CASPI segment do not reflect ongoing business results. However, management believes that these items are indicative of the performance of certain businesses and product lines, results of continuous efforts to reduce costs, and results of other actions to improve the profitability of the company. Management believes that investors can better evaluate and analyze historical and future business trends if they also consider the reported corporate, division and segment results, respectively, without the identified items. Management utilizes corporate earnings and division and segment sales revenue and operating results excluding the identified items in the measures it uses to evaluate corporate, division and segment performance and in determining certain performance-based compensation. These measures are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as alternatives to the GAAP measures of performance. Table 8 in the accompanying third-quarter 2004 financial tables reconciles operating earnings, net earnings and earnings per share on a GAAP basis, as reflected in Eastman’s Consolidated Statements of Earnings to operating earnings, net earnings and earnings per share excluding asset impairments and restructuring charges, other operating income, and the net deferred tax benefit. Tables 4a and 4b in the accompanying third-quarter 2004 financial tables reconcile corporate and Eastman Division sales revenue on a GAAP basis to sales revenue excluding restructured, divested, and consolidated product lines sales revenue from the CASPI segment.
In addition, the Company has chosen to present CASPI sales revenue, operating results, and asset impairments and restructuring charges attributable to restructured, divested, and consolidated product lines. Table 5 in the accompanying third-quarter 2004 financial tables provides this information on a GAAP basis.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
The following exhibit is furnished pursuant to Item 9.01:
| 99.01 |
Public release by the registrant on October 28, 2004 of third quarter 2004 financial results. SIGNATURES |
| EASTMAN CHEMICAL COMPANY - EMN |
|
October 28, 2004 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
|
|
| |
Eastman Chemical Company |
|
|
|
|
By: |
/s/ Richard A. Lorraine |
| |
|
| Name: |
Richard A. Lorraine |
| Title: |
Senior Vice President and Chief Financial Officer |
Date: October 28, 2004
| EASTMAN CHEMICAL COMPANY - EMN |
|
October 28, 2004 |
EXHIBIT INDEX
|
EXHIBIT
NUMBER |
|
DESCRIPTION |
| |
|
|
|
99.01 |
|
Public release by the registrant on October 28, 2004 of third quarter 2004 financial results. |